UK & Ireland Implanters' Registry Evaluates Initial Experience of Medtronic's Evolut R TAVR Device

 

November 6, 2018—The results of the initial experience of a large, self‐expanding, and fully recapturable transcatheter aortic valve replacement (TAVR) device in the United Kingdom and Ireland were published by Cameron Dowling, MD, et al in Catheterization and Cardiovascular Interventions. The UK & Ireland Implanters’ registry is a multicenter registry that reported on real‐world experience with the novel 34-mm Evolut R TAVR device (Medtronic), which is designed to treat patients with a large aortic annulus.

The investigators prospectively collected the clinical, procedural, and 30‐day outcome data from all patients that received the 34-mm Evolut R valve across 17 participating centers in the United Kingdom and Ireland between January 2017 and April 2018.

The primary efficacy outcome was the endpoint of device success as defined by the Valve Academic Research Consortium‐2 (VARC‐2). The primary safety outcome was the VARC‐2–defined composite endpoint of early safety at 30 days.

As summarized in Catheterization and Cardiovascular Interventions, a total of 217 patients underwent attempted implant. Mean age was 79.5 ± 8.8 years and Society of Thoracic Surgeons score 5.2% ± 3.4%. Iliofemoral access was used in 91.2% of patients.

The investigators reported that device success was 79.7%. Mean gradient was 7.0 ± 4.6 mm Hg and effective orifice area 2.0 ± 0.6 cm2. Paravalvular regurgitation was more than mild in 7.2%. A new permanent pacemaker was implanted in 15.7%. Early safety was demonstrated in 91.2%. At 30 days, all‐cause mortality was 3.2%, stroke 3.7%, and major vascular complication 2.3%.

Real‐world experience of the 34-mm Evolut R transcatheter aortic valve demonstrated acceptable procedural success, safety, valve function, and incidence of new permanent pacemaker implantation, concluded the investigators in Catheterization and Cardiovascular Interventions.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.